657
Views
13
CrossRef citations to date
0
Altmetric
Drug Profile

Induction and maintenance of procedural sedation in adults: focus on remimazolam injection

, &
Pages 411-426 | Received 28 Dec 2020, Accepted 08 Mar 2021, Published online: 17 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Qinxue Hu, Xing Liu, Chengli Wen, Duo Li & Xianying Lei. (2022) Remimazolam: An Updated Review of a New Sedative and Anaesthetic. Drug Design, Development and Therapy 16, pages 3957-3974.
Read now
Xianwen Liu, Baofeng Ding, Fu Shi, Yang Zhang, Lei Liu, Yongwei Sha & Tonghang Zhao. (2021) The Efficacy and Safety of Remimazolam Tosilate versus Etomidate-Propofol in Elderly Outpatients Undergoing Colonoscopy: A Prospective, Randomized, Single-Blind, Non-Inferiority Trial. Drug Design, Development and Therapy 15, pages 4675-4685.
Read now

Articles from other publishers (11)

Feng Gao & Yujia Wu. (2023) Procedural sedation in pediatric dentistry: a narrative review. Frontiers in Medicine 10.
Crossref
Yuan-rui Zhao, Ke-sheng Huang, Guo Hou, Lan Yao, Li-ping Lu, Song Xu, Ying-tao Lian, Zhun Yao & Zhui Yu. (2023) Efficacy and safety of remimazolam-based sedation for intensive care unit patients undergoing upper gastrointestinal endoscopy: a cohort study. World Journal of Emergency Medicine 14:1, pages 31.
Crossref
奕洁 李. (2023) The Hemodynamic Effects of Remimazolam on Patients Undergoing Laparoscopic Gastric Cancer Surgery. Advances in Clinical Medicine 13:10, pages 16572-16576.
Crossref
Jian Guo, Yitao Qian, Xiaojin Zhang, Shuangjian Han, Qinye Shi & Jianhong Xu. (2022) Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiology 22:1.
Crossref
Xiaoyan Chen, Jiancheng Zhang, Shiying Yuan & Haiyan Huang. (2022) Remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the ICU: a prospective dose‒response study. Scientific Reports 12:1.
Crossref
Ximei Wang, Xiaolei Hu, Nianyue Bai, Lie Li, Min Zhang, Zhigang Cheng & Qulian Guo. (2022) Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase Ⅲ trial. Frontiers in Pharmacology 13.
Crossref
Xingfang Chen, Deqian Xin, Guangjun Xu, Jing Zhao & Qing Lv. (2022) The Efficacy and Safety of Remimazolam Tosilate Versus Dexmedetomidine in Outpatients Undergoing Flexible Bronchoscopy: A Prospective, Randomized, Blind, Non-Inferiority Trial. Frontiers in Pharmacology 13.
Crossref
Zhaoyang Qi, Ziying Li, Mo Zhu, Xiaohua Zhang, Guisen Zhang, Tao Zhuang, Yin Chen & Ling Huang. (2022) Design, synthesis, and evaluation of phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents. Bioorganic & Medicinal Chemistry Letters 57, pages 128497.
Crossref
Kyung Mi Kim. (2022) Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesthesia and Pain Medicine.
Crossref
Juan Li, Di Zhou, Yang Jin, Hong‐Su Zhou, Chang‐Le Fang, Zhao‐Qiong Zhu & Liu‐Lin Xiong. (2021) Difference between remimazolam toluenesulfonic acid and propofol in waking quality and conscious state after general anesthesia. Ibrain 7:3, pages 171-180.
Crossref
Arnold Lee & Matt Shirley. (2021) Remimazolam: A Review in Procedural Sedation. Drugs 81:10, pages 1193-1201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.